30-01-2013
13. Meningococcal conjugate vaccines (MCV). (Minimum age: 6 weeks for Hib-MenCY, 9 months for Menactra [MCV4-D],
2 years for Menveo [MCV4-CRM]).
Routine vaccination:
• Administer MCV4 vaccine at age 11–12 years, with a booster dose at age 16 years.
• Adolescents aged 11 through 18 years with human immunodeficiency virus (HIV) infection should receive a 2-dose primary series of MCV4, with at least 8 weeks between doses. See MMWR 2011; 60:1018–1019 available at:http://www.cdc.gov/mmwr/pdf/wk/mm6030.pdf 
.
• For children aged 9 months through 10 years with high-risk conditions, see below.
Catch-up vaccination:
• Administer MCV4 vaccine at age 13 through 18 years if not previously vaccinated.
• If the first dose is administered at age 13 through 15 years, a booster dose should be administered at age 16 through 18 years with a minimum interval of at least 8 weeks between doses.
• If the first dose is administered at age 16 years or older, a booster dose is not needed.
ΜΑΡΙΟΣ ΑΝΔΡΕΟΥ
ΠΑΙΔΙΑΤΡΟΣ
ΔΙΕΥΘΥΝΤΗΣ ΚΠΜ
